Tresiba 100 U/mL
insulin degludec · INJECTION, SOLUTION · Novo Nordisk
No Recall HistoryCurrently in Shortage
Plain English
Tresiba is a injection, solution containing insulin degludec at 100 U/mL, taken subcutaneous. Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- Tresiba
- Generic Name
- insulin degludec
- NDC Code (Product)
0169-2662- Manufacturer
- Novo Nordisk
- Strength
- 100 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA203314
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 11/21/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Tresiba used for?
Tresiba contains insulin degludec. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Tresiba a controlled substance?
Tresiba is not classified as a controlled substance by the DEA.
What is the generic name for Tresiba?
The generic name for Tresiba is insulin degludec. There are 8 other brand versions of insulin degludec.
What is the NDC code for Tresiba 100 U/mL?
The NDC (National Drug Code) for Tresiba 100 U/mL is 0169-2662, listed by Novo Nordisk.